Alibaba Group's share price of $127.25 sits materially below the model-derived fair value of $156.24, leaving a residual gap of 22.8 percent. That gap equates to roughly $29 per share in what can be characterized as a remaining China risk discount despite a fundamental re-rating since the peak of investor concern.
P/E compression in context
The arc of Alibaba's five-year P/E multiple captures the market's shifting view on China risk. At the trough of investor sentiment in FY2024 the company was valued at 13.1x P/E and 3.5x EV/EBITDA - levels consistent with a regulated utility valuation rather than a growing technology and e-commerce platform. That represented a near 50 percent de-rating from a pre-crackdown multiple of 25.5x.
By FY2026 the multiple had recovered to 18.6x P/E, reflecting a partial removal of the extreme regulatory fear that drove the FY2024 lows. However, this recovery stops short of the pre-crackdown multiple near 25x. The current 'new normal' multiple range of roughly 18 to 19x implies the market continues to apply an approximately 25 to 30 percent structural haircut to account for regulatory and geopolitical uncertainty in China.
Fundamentals strengthened while multiples fell
Crucially, Alibaba's operating results improved during the interval when valuation multiples sank to their lowest levels. Revenue expanded from $130.4 billion to $148.4 billion, an increase of 13.8 percent. Over the same span net income rose from $11.0 billion to $15.4 billion, a 39 percent gain. Gross margins widened from 37.7 percent to 39.8 percent. These data points show the underlying business was strengthening even as the market applied large discounts.
Current headline valuation and market metrics
Key figures at the present trading price include:
- Price: $127.25
- Market capitalization: $284.5 billion
- P/E: 18.6x
- EV/EBITDA: 12.2x
- Model fair value: $156.24
Three layers of China risk pricing
The valuation framework separates how the market priced Alibaba across three reference points: the FY2024 peak fear point, the FY2026 current point, and the model-derived fair value. The following table contains the metrics used to illustrate these layers.
| Metric | FY2024 (Peak Fear) | FY2026 (Now) | Fair Value | Implied Discount |
|---|---|---|---|---|
| P/E | 13.1x | 18.6x | ~24.5x | ~24% |
| EV/EBITDA | 3.5x | 12.2x | ~16x* | ~24% |
| Price | $72.36 | $127.25 | $156.24 | 22.8% |
*Implied fair-value P/E derived from fair value divided by current EPS.
Market consensus among sell-side analysts is notably more optimistic than the model's fair value. The analyst consensus implies roughly 51 percent upside versus the current share price. That divergence between sell-side targets and a model that incorporates a China risk haircut can itself be interpreted as a sign that sell-side forecasts may not fully price geopolitical or regulatory adjustments into traditional valuation models.
What beta and risk measures reveal
One of the more revealing market signals is Alibaba's beta of 0.51. Despite the stock moving between $72 and $132 over a two-year period, a beta substantially below 1.0 indicates that systematic market risk is relatively low. The implication is that much of the price volatility reflects idiosyncratic, company-specific regulatory risk tied to China rather than broad market correlation. In other words, the market treats Alibaba as low-correlation but high-specific-risk.
Residual discount - optionality or further downside?
Arguments on both sides of the trade persist.
Bull case - The remaining 22.8 percent gap to fair value is the final fragment of peak-China-fear pricing. Revenue has resumed growth, margins are expanding, return on equity recovered to 10.2 percent, and the shares trade at a P/E that would appear undemanding for a global e-commerce business. From this perspective the roughly $29 per-share differential represents optionality.
Bear case - Valuation based on the Ben Graham formula places Alibaba at $76.38, implying downside of 38.8 percent from the current price. Recent operational metrics cited by detractors include revenue growth slowing to 2.7 percent, EPS growth at -17.2 percent, and a negative free cash flow yield of -2.5 percent. Those figures support the view that the fair value model used may be optimistic about the future regulatory path in China.
Conclusion
At its FY2024 trough the market arguably over-priced China-related risk, valuing a business that was posting revenue growth and margin expansion at a multiple closer to 13x P/E. Multiples have partially rebounded into the high teens, but the persistent roughly $29 gap to the model fair value indicates the market continues to demand a significant geopolitical premium. That premium could compress rapidly if sentiment around regulation improves, or it could widen if regulatory conditions deteriorate further.